Technology licensing service

eagle-i ID

Resource Type

Properties

1. Resource Description

   The Tech Transfer Office can provide licenses for the following commercialization opportunities: * TUMOR CYTOTOXICITY INDUCED BY MODULATORS OF THE CXCR4 RECEPTOR - "This invention relates to the use of Gp120 and Nef proteins of retroviruses, or peptides of these proteins, as therapeutic agents against carcinomas." * METHOD FOR IDENTIFYING SALT-SENSITIVE PERSONS - "This invention relates to evaluation of salt sensitivity as it relates to propensity to present or develop hypertension." * ANTI –CHEMOKINE AND –ASSOCIATED RECEPTOR ANTIBODIES AND USES FOR INHIBITION OF INFLAMMATION - "This invention relates to antibodies or the use of antibodies, against precise chemokines or chemokine receptors, that mediate certain inflammatory diseases, e.g., chronic obstructive pulmonary disease (COPD), inflammatory bowel disease (IBD), interstitial cystitis." * ANTI –CHEMOKINE AND –ASSOCIATED RECEPTOR ANTIBODIES AND USES FOR INHIBITION OF CANCER GROWTH AND METASTASIS - "This invention relates to antibodies or the use of antibodies, against precise chemokines or chemokine receptors, to provide a means of inhibiting the growth and/or metastasis of tumor cells." * TRYPANOSOME DERIVED APOPTOTIC FACTORS (TAF) - "This invention relates to the use of anti-TAF monoclonal antibody to inhibit cell death of microvascular endothelial, brain and other cells. It is the purpose of this invention to provide antibodies that neutralize or abrogate TAF activity." * MODULATING VACCINE AGAINST HIV-1 NEF PROTEIN INDUCED LYMPHOCYTE DEPLETION - "The invention comprises of a peptide prophylactic or therapeutic vaccine that will provide protection against Nef-mediated pathogenesis, which causes T cell depletion seen in full-blown AIDS." * NEUREGULINS AS REGULATORS OF STEM CELL MIGRATION - "This invention relates to the administration of neuregulin-1 to mobilize endogenous neuronal stem cells to the damaged areas of the brain, following stroke or other neurodegenerative disorders." * RAD ATTENUATION OF VASCULAR LESION FORMATION AND TREATMENT OF VASCULAR DISEASES - "It is the purpose of this technology to provide a means for preventing and treating restenosis and atherosclerosis." * RAD INHIBITION OF CARDIOMYOCYTE HYPERTROPHY & USES FOR TREATING OF HEART DISEASES - "This invention describes a method to identify and/or to treat cardiac hypertrophy, respectively." * CAGE DISPENSER FOR MEASURING FOOD INTAKE IN LABORATORY RODENTS - "This invention relates to use of food dispensers for studies requiring careful measurement of intake by animals." * SPLICE VARIANTS OF BRCA1 - "This invention relates to the identification of i) a nucleic acid sequence encoding human BRCA1a and BRCA1b, ii) a protein encoded by the nucleic acid sequence of BRCA1a and BRCA1b, iii) a vector comprising the nucleic acid sequence of BRCA1a and BRCA1b, iv) a host cell transfected with BRCA1a and BRCA1b and v) an in vitro method of identifying agents capable of modulating the amount or activity of BRCA1a or BRCA1b proteins in cells." * NOVEL NANOPARTICLES FOR DELIVERY OF INERT AND BIOLOGICALLY ACTIVE AGENTS - "The current technology uses a novel and relatively inexpensive technique to generate polycaprolactone-coated biopolymer-polyethylene glycol nanoparticles, which allows for controlling the size of the therapeutic or diagnostic particle (100 nm to 50 um; + 10% of mean size), > 99% loading efficiency and polymer- or ligand-coating for controlled-, protected-, and targeted-release of its contents." * HETEROCYCLIC AND DIPHENYL KETONES HAVING CYTOTOXIC PROPERTIES - "This invention relates to the discovery of novel heterocyclic and dialkoxyphenyl compounds which possess potent cytotoxic activity." * A HIGH THROUGHPUT METHOD FOR HAPLOTYPE DETERMINATION - "This invention provides an improved, more reliable method of haplotype determination." * COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF NEUROINJURY AND METHODS OF USE THEREOF - "This invention relates to post-trauma administration of NRG-1 by any known route of administration following TBI to prevent secondary neuronal injury and inflammation." * DETECTION OF PLASMODIUM FALCIPARUM ANTIGENS IN SALIVA OF MALARIA PATIENTS - "This invention relates to detection of Plasmodium falciparum antigens in saliva of malaria patients." * METHODS FOR STORAGE AND RETRIEVAL OF FUNCTIONAL MATURE RETINAL CELLS - "The present invention relates generally to the field of cell isolation and storage and, in particular, to the storage and retrieval of functional mature retinal cells." * DETECTION OF HIV-RELATED PROTEINS IN URINE - "This invention relates to methods for diagnosis and, in particular, to methods for detecting HIV infection, diagnosing HIV or HIV-associated diseases using biomarkers in the urine."

2. Service Provided by

   Office of Technology Transfer, Morehouse School of Medicine

3. Website(s)

   http://www.msm.edu/files/Technology%20Licensing%20Brochure_2010.pdf

4. ERO_0001053

   No